Author

O. Wald

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Panet· 2 shared E. Oiknine-Djian· 2 shared M. Oberbaum· 2 shared O. Alfi· 2 shared O. Vorontsov· 2 shared O. Wandel· 2 shared U. Izhar· 2 shared Z. Zakay-Rones· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Panet

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications

E. Davis, S. Avniel-Polak, S. Abu-Kamel, I. Antman, T. Saadoun, C. Brim, A. Bel-Ange, K. Atlan, T. Tzur, F. Abu-Akar, O. Wald, U. Izhar, M. Hecht, S. Grozinsky-Glasberg, Y. Drier

This study identifies three regulatory subtypes of lung neuroendocrine tumors through ChIP-seq and RNA-seq, revealing distinct transcription factor signatures and therapeutic vulnerabilities.

bioRxiv · Nov 17, 2023Cancer Biology

SARS-CoV-2 Omicron is specifically restricted in its replication in human lung tissue, compared to other variants of concern

O. Alfi, M. Hamdan, O. Wald, A. Yakirevitch, O. Wandel, E. Oiknine-Djian, B. Gvili, H. Knoller, N. Rozendorn, H. Golan Berman, S. Adar, O. Vorontsov, M. Mandelboim, Z. Zakay-Rones, M. Oberbaum, , D. Wolf

This study compares SARS-CoV-2 Omicron replication in human lung and nasal tissues to other variants, finding restricted replication in lungs and a stronger interferon response.

bioRxiv · Mar 31, 2022 · PreprintMicrobiology

Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract

O. Alfi, A. Yakirevich, O. Wald, O. Wandel, U. Izhar, E. Oiknine-Djian, Y. Nevo, S. Elgavish, E. Dagan, O. Madgar, G. Feinmesser, E. Pikarsky, M. Bronstein, O. Vorontsov, W. Jonas, , D. G. Wolf

This study compares SARS-CoV-2 and influenza virus infection in human nasal and lung tissues, revealing distinct innate immune responses in the upper and lower respiratory tract.

bioRxiv · Mar 8, 2021Microbiology